Toxicity Comparison Tool Helps Patients Choose Between Fruquintinib and Regorafenib

♥ LIVING WITH CRC

Researchers developed a weighted toxicity score to help patients and clinicians compare side effects between two later-line treatment options, supporting more informed treatment decisions in metastatic colorectal cancer. (Clinical Colorectal Cancer)